Aida Cuenca‐Royo

Effect of a Lifestyle Intervention Program With Energy-Restricted Mediterranean Diet and Exercise on Weight Loss and Cardiovascular Risk Factors: One-Year Results of the PREDIMED-Plus Trial

Jordi Salas‐Salvadó, Andrés Díaz‐López, Miguel Ruiz‐Canela et al. · Diabetes Care · 2018 · 449 citations · Full text

Medicine, Nutrition, Nutritional Sciences +17

Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial

Rafael de la Torre, Susana Solá, Gimena Hernández et al. · The Lancet Neurology · 2016 · 286 citations

Medicine, Neurology, Neuroscience +9

Epigallocatechin‐3‐gallate, a DYRK1A inhibitor, rescues cognitive deficits in <scp>D</scp>own syndrome mouse models and in humans

Rafael de la Torre, Susana Solá, Meritxell Pons‐Espinal et al. · Molecular Nutrition & Food Research · 2013 · 279 citations

Life Sciences, Genetics, Neuroscience +17

Psychometric properties of the CAST and SDS scales in young adult cannabis users

Aida Cuenca‐Royo, Albert Sánchez‐Niubò, Carlos G. Forero et al. · Addictive Behaviors · 2012 · 104 citations

Nursing, Behavioral Sciences, Psychology +15

Type 2 diabetes and cognitive impairment in an older population with overweight or obesity and metabolic syndrome: baseline cross-sectional analysis of the PREDIMED-plus study

Núria Mallorquí‐Bagué, María Lozano‐Madrid, Estefanía Toledo et al. · Scientific Reports · 2018 · 104 citations · Full text

Medicine, Geriatric Medicine, Diabetology +16